NCT00024934
- Conditions
- Blood Protein Disorders, Dysgammaglobulinemia, Hematologic Diseases, +5 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
Clinical trial condition
Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.
NCT00024934
NCT02600299
NCT00362830
NCT00388557
NCT01634126
NCT02900950
NCT02210260
NCT01447225
NCT00861432
NCT00965341